Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kenta OKADA
Olmesartan Medoxomil, an Angiotensin II Receptor Blocker Ameliorates Insulin Resistance and Decreases Triglyceride Production in Fructose-Fed Rats
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Related publications
Angiotensin II Receptor Blocker Ameliorates Stress-Induced Adipose Tissue Inflammation and Insulin Resistance
PLoS ONE
Multidisciplinary
Chronic Insulin Infusion Normalizes Blood Pressure and the Gene Expressions of Angiotensin II Type 1 Receptor in Fructose-Fed Rats
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Salt Overload in Fructose-Fed Insulin-Resistant Rats Decreases Paraoxonase-1 Activity
Nutrition and Metabolism
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
Direct Renin Inhibitor Prevents and Ameliorates Insulin Resistance, Aortic Endothelial Dysfunction and Vascular Remodeling in Fructose-Fed Hypertensive Rats
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Direct Action of an Angiotensin II Receptor Blocker on Angiotensin II-induced Left Atrial Conduction Delay in Spontaneously Hypertensive Rats
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Effect of TNF- -Converting Enzyme Inhibitor on Insulin Resistance in Fructose-Fed Rats
Hypertension
Internal Medicine
The Angiotensin II Type 1 Receptor Blocker Olmesartan Preferentially Improves Nocturnal Hypertension and Proteinuria in Chronic Kidney Disease
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Summertime Dosage-Dependent Hypersensitivity to an Angiotensin II Receptor Blocker
